Télécharger la présentation
La présentation est en train de télécharger. S'il vous plaît, attendez
Publié parGaston Rousseau Modifié depuis plus de 7 années
2
IL-2 First signal =CTL- Precurseurs
3
Molécules effectrices des Lymphocytes cytotoxiques T (CTL)
Solubles Membranaires Cytokines : INF-g, TNF-b Ligand de Fas Cytotoxines : Perforine Granzyme
4
La cytolyse TCR HLA Cl1 CTL cible Microtubules Golgi apoptose
5
The control of intracellular proteins by MHC Cl I molecules
killing Cytoplasmic Foreign protein
6
The control of intracellular proteins by MHC Cl I molecules
CTL deleted Or tolerized No killing Self - protein
8
Mediators of NK cells functional effects
Tumor or virus infected cells Direct lysis Perforine /granzyme Cytokine secretions : INFg +++++ TNFa+++ GMCSF+++ Chimiokines : CCL4, 5 & 22
9
Cytotoxycité des NK( anti virale ou anti-tumorale) déclenchée par le « soi manquant »
10
Famille des KIRs (Killer Ig like Receptors) : Exprimés chez les primates ; gènes regroupés sur le chromosome 19 (= leucocyte receptor complex, 150 Kb) Monomères, homo et hétérodimers (14 molécules connues chez l’homme) Ligands : molécules HLA de classe I : contact sur les hélices alpha des poches à peptide, sur quelques résidus seulement => spécificité pour un sous type de HLA I (Exemple de spécificité : KIR2DL2 peut se lier à HLA-Cw1, w3, w7 et w8.KIR3DL1 à bw4 ) KIRs inhibiteurs (long tailed) KIR activateurs (short tailed) Molécule DAP 12 KIR2DL KIR3DL KIR2DS Domaine ITIM domaine ITAM
11
CLOSE KIR, TCR and HLA-Cl1
12
Intracellular modules of immunological receptors
Activator = ITAM : …..ILVxxYLV….. (ex : CD3 chains, syk kinases NK activs.) Inhibitor = ITIM : …..YxxLx…..Yxxl… (ex : SHP & SHIP, NK inhibs.)
13
Inhibiteurs Activateurs
Famille des lectines de type II, (Ly49) : exprimée chez les rongeurs Ligands : résidus sucrés des molécules HLA de classe I Inhibiteurs Activateurs Se lie probablement à une Molécule de type Dap 12 ITIM Homodimers ; genes located on mouse chr. 6 => NKC gene complex
14
Famille des lectines de type C
: exprimée chez les rongeurs et les primates Inhibiteurs activateurs Heterodimers (2° chaine = CD94) CD94 DAP12 ITIM ITAM Gènes sur le complexe NKC (chr. 6 souris; 12 primates) Lient HLA classiques non
15
The C-lectin like NKG2D Dap10 Homodimer ?
16
CLOSE
17
Activators : The NKp family
3 Ig superfamily members distincts from KIRS Specific for NK cells Charged residues in TM segment => module association CD3zeta,, FcERIg, DAP12… Receptor adaptor ligand NKp FCeRIg or CD3z ? NKp FCeRIg or CD3z influenza HA,… NKp Dap influenza HA,… Central role in Nk cell mediated killing of cancer cells NKc mediated killing of viral cells blocked by anti - HA
18
NK cells express three types of receptors: activating, inhibitory and co-stimulatory receptors.
Target cell NK cell
19
NK cell activities : a delicate balance
Interacting cell Bacterial or viral product MHC molecules Activating receptors Inhibitory receptors Inhibitory module = ITIM : …..YxxLx…..Yxxl… SHP & SHIP Pases Activator module = ITAM : …..ILVxxYLV….. Syk kinases NK cell
20
Organization of the KLR Locus
21
Genomic structure of lectin-like receptors encoded in the natural killer gene complex.
22
Inhibitory NK receptors for MHC
23
Activating NK cell receptors and their ligands
24
Activating receptors and their intracellular modules
25
NKG2D et les infections virales : Pour contrarier les virus
Cellule inféctée Par HCMV
26
Ly49h : Un recepteur activateur qui renforce les défenses anti-CMV
Cellule inféctée par MCMV m157
27
Les protéines de stress et les NK
Stress ; transformation maligne
28
NK cells D cells cross-talk in tissues
ED TISSUES < previous next > NK cells D cells cross-talk in tissues
29
NATURAL KILLER CELLS AND DENDRITIC CELLS: RENDEZVOUS IN ABUSED TISSUES
< previous next >
30
Dendritic cells are equipped to ingest living, apoptotic and necrotic cells
Immune complexes Osponized live or dead cells Necrotic cells Toll R FcR CR3/4 PSR CD36 aVb5 CD91 Apoptotic cells
31
CLOSE Priming NK Cells
32
NK cells differentiation I
< previous next > NK cells differentiation I
33
NK Cell differentiaton 2
34
NK cells in vitro AT DOES IT TAKE TO MAKE A NATURAL KILLER?
< previous next > NK cells in vitro
35
HLA-class I specificity
KIR HLA-class I specificity KIR2DL1 Group 2 HLA-C alleles expressing Lys80 (such as, HLA-Cw2, -Cw4, -Cw5, -Cw6) KIR2DL2/3 Group 1 HLA-C alleles expressing Asn80 (such as HLA-Cw1, -Cw3, -Cw7, -Cw8) KIR3DL1 HLA-Bw4 alleles (e.g. HLA-B27) HLA-class I allele specificity of the main inhibitory KIR.
36
Donor NK cell allospecificity for ‘missing self’ on recipient targets.
37
Mismatch KIR lors d’une greffe hématopoïétique haplo-identique
Farag et al, Blood 2002 (A) In this example, donor and recipient are HLA haplotype–mismatched and are KIR-epitope mismatched at the HLA-C locus. The donor NK cell clones expressing KIR2DL1 recognize and are inhibited by an epitope shared by the group 2 HLA-C alleles (HLA-Cw2, 4, 5, and 6). The recipient’s leukemic blasts express HLA-Cw3, a member of the group 1 HLA-C alleles, and are, therefore, not recognized by the donor’s KIR2DL1, and activation of donor NK cell occurs with leukemic cell lysis. (B) Here, donor and recipient are haplotype-mismatched, but express HLA-C alleles of the same supertype group 2 (HLA-Cw2, 4, 5, and 6). Therefore, donor NK cell clones expressing the inhibitory KIR2DL1 recognize a “selfepitope” (HLA-Cw4) on the recipient’s cells with inhibition of lysis of leukemic blasts. KIR epitope mismatching exerts another level of graft alloreactivity and a potent GVL effect.
38
Kaplan-Meier estimates of the probability
of leukaemia relapse of 40 high-risk AML recipients
39
Kaplan-Meier estimates of the probability
of survival of 40 high-risk AML recipients
40
Two types of memory T cells
virgin CD62L +++ CCR7 + CD29- 45RA-O+ Blood to lymph nodes Ag stimulation CD62L +++ CCR7+ CD29+++ 45RA+,RO- Central memory Stay in LN Ag stimulation CD62L - CCR7- CCR5, 4, 2 et 3 high CD29+++ 45RA+,RO- Goes to Inflammatory area Effector memory
41
T cell exhaustion during chronic viral infection
42
Reinvigorating Exhausted T Cells
Freeman GJ JEM, sept 06 Resolved Infection Chronic Infection
Présentations similaires
© 2024 SlidePlayer.fr Inc.
All rights reserved.